Imunon CEO granted 5,504 shares as salary

Imunon’s President and CEO received common stock in lieu of part of base salary, increasing direct and 401(k) holdings without any reported 10b5-1 plan.

Rhea-AI Filing Summary

Imunon, Inc. (IMNN) reported that President and CEO Stacy Lindborg received a grant of 5,504 shares of common stock on September 11, 2026 as a grant, award, or other acquisition. The stock was granted in lieu of cash for a portion of base salary, at a reported value of $1.47 per share, bringing Lindborg’s directly held common stock to 105,580 shares. Lindborg also holds 778 shares indirectly through a 401(k) plan. No Rule 10b5-1 trading plan is reported for these transactions.

Insider Trade Summary

Grant/Award: 5,504 shares

Grant/Award 2 txns

Insider Lindborg Stacy

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	5,504	$1.47	$8K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 105,580 shares (Direct); Common Stock — 778 shares (Indirect, By 401(k) Plan)

Footnotes (1)

1. F1. Stock granted in lieu of cash for portion of base salary

Key Figures

Shares granted: 5,504 shares Grant value per share: $1.47 per share Direct holdings after grant: 105,580 shares +2 more

5 metrics

Shares granted 5,504 shares Common stock grant on September 11, 2026

Grant value per share $1.47 per share Value assigned to the 5,504-share stock grant

Direct holdings after grant 105,580 shares Directly held Imunon common stock following the grant

Indirect 401(k) holdings 778 shares Common stock held indirectly by 401(k) Plan as of September 11, 2026

Acquisition transactions in filing 1 transaction One grant, award, or other acquisition reported

Key Terms

grant, award, or other acquisition, in lieu of cash, 401(k) Plan

3 terms

grant, award, or other acquisition financial

"classified as a grant, award, or other acquisition of common stock"

in lieu of cash financial

"Stock granted in lieu of cash for portion of base salary"

401(k) Plan financial

"778 shares indirectly through a 401(k) Plan"

A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did IMNN’s President and CEO Stacy Lindborg report on this Form 4?

Stacy Lindborg reported a grant of 5,504 shares of Imunon common stock on September 11, 2026, classified as a grant, award, or other acquisition of common stock.

At what value was the IMNN stock grant to Stacy Lindborg recorded?

The 5,504-share stock grant to Stacy Lindborg was recorded at $1.47 per share, and was designated as stock granted in lieu of cash for a portion of base salary.

How many IMNN shares does Stacy Lindborg hold directly after this transaction?

After the September 11, 2026 grant, Stacy Lindborg directly holds 105,580 shares of Imunon common stock, according to the reported post-transaction holdings.

Does Stacy Lindborg have any indirect holdings of IMNN shares?

Yes. In addition to direct holdings, Stacy Lindborg has 778 shares of Imunon common stock held indirectly by a 401(k) Plan, as reported on the same date.

Was the IMNN stock grant to Stacy Lindborg made under a Rule 10b5-1 trading plan?

No. The filing indicates that the Rule 10b5-1 checkbox is not selected, so no Rule 10b5-1 trading plan is reported in connection with these transactions.

What is the nature of the compensation for Stacy Lindborg in this IMNN Form 4?

The Form 4 states that the common stock was granted in lieu of cash for a portion of base salary, indicating that part of Stacy Lindborg’s compensation was paid in Imunon stock instead of cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 12:43 PM Accepted by SEC EDGAR 09/15/2026 - 12:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lindborg Stacy

(Last) (First) (Middle)

C/O IMUNON, INC.

997 LENOX DRIVE, SUITE 100

(Street)

LAWRENCEVILLE NEW JERSEY 08648

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Imunon, Inc. [ IMNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2026		A		5,504(1)	A	$1.47	105,580	D
Common Stock								778	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Stock granted in lieu of cash for portion of base salary

	/s/ Jeffrey W Church, Attorney in Fact for Stacy R. Lindborg	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)